Britannia Life Sciences Inc.
BLAB
CNSX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -29.02% | 6.23% | 1,772.94% | -86.25% | -17.59% |
| Total Receivables | 32.90% | 103.29% | 88.48% | 45.06% | -6.87% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -19.71% | -31.03% | 435.87% | -2.13% | -44.71% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 0.42% | -1.52% | -74.91% | 0.97% | 4.17% |
| Total Current Assets | -24.51% | 9.04% | 468.41% | -63.59% | -13.41% |
|
|
|||||
| Total Current Assets | -24.51% | 9.04% | 468.41% | -63.59% | -13.41% |
| Net Property, Plant & Equipment | -19.65% | -17.75% | -14.02% | -14.16% | -5.63% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 1.98% | 6.53% | 117.29% | 2.96% | -10.96% |
|
|
|||||
| Total Accounts Payable | -25.31% | -60.84% | 148.60% | -5.36% | -32.51% |
| Total Accrued Expenses | -1.54% | -16.23% | -13.79% | 38.83% | -12.94% |
| Short-term Debt | 0.00% | -1.42% | 0.00% | -2.30% | 6.37% |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -6.50% | -4.21% | 2.06% | -3.27% | 4.68% |
| Total Finance Division Other Current Liabilities | -2.00% | -- | -- | -- | -- |
| Total Other Current Liabilities | -2.00% | -- | -- | -- | -- |
| Total Current Liabilities | -12.93% | -41.08% | 60.83% | 11.95% | -23.80% |
|
|
|||||
| Total Current Liabilities | -12.93% | -41.08% | 60.83% | 11.95% | -23.80% |
| Long-Term Debt | -- | -- | -- | 39.14% | 4.35% |
| Short-term Debt | 0.00% | -1.42% | 0.00% | -2.30% | 6.37% |
| Capital Leases | -31.75% | -30.77% | -30.80% | -24.32% | -12.69% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -2.01% | -- | -- | -- | -- |
| Total Liabilities | -12.36% | -36.44% | -6.75% | 20.88% | -15.39% |
|
|
|||||
| Common Stock & APIC | -1.11% | -1.53% | 1.59% | -2.08% | 5.39% |
| Retained Earnings | 85.80% | 158.18% | 84.02% | -0.80% | -10.87% |
| Treasury Stock & Other | -5.58% | -6.38% | 3.26% | -6.23% | -12.58% |
| Total Common Equity | 4.14% | 18.58% | 246.52% | -10.83% | -7.22% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 4.14% | 18.58% | 246.52% | -10.83% | -7.22% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 4.14% | 18.58% | 246.52% | -10.83% | -7.22% |
|
|
|||||